Background: Despite an increase in the number of therapies available to treat patients with
immune thrombocytopenia (ITP), there are minimal data from randomized trials to assist …

Immune thrombocytopenia (ITP) is commonly encountered in clinical practice. In 1996 the
American Society of Hematology published a landmark guidance paper designed to assist …

Background Although laparoscopic splenectomy (LS) has become the standard approach
for most splenectomy cases, some areas still remain controversial. To date, the indications …

Immune thrombocytopenic purpura (ITP) is an autoimmune disorder characterized by a low
circulating platelet count caused by destruction of antibody-sensitized platelets in the …

Immune thrombocytopenia (ITP) has historically been thought to occur in 2 distinct forms:
childhood ITP and adult ITP. This division is based largely on the presumption that …

Background. Since 1991, laparoscopic splenectomy (LS) has gained acceptance in the
treatment of hematologic disorders, including idiopathic thrombocytopenic purpura (ITP) …

Background Demographics, outcome, and management of idiopathic thrombocytopenic
purpura (ITP) in children present differences between countries. Although several factors …

Background Data on second‐line treatment options for pediatric patients with immune
thrombocytopenia (ITP) are limited. Thrombopoietin receptor agonists (TPO‐RA) provide a …

Background Splenectomy is an effective procedure for children and adults with severe or
refractory idiopathic thrombocytopenic purpura (ITP). Data regarding pediatric patients are …

Most children with immune thrombocytopenia (ITP) have transiently low platelet counts and
do not suffer from bleeding. Treatments with steroids, immunosuppression or splenectomy …